Advertisement

Prostate biopsy - Biotech, Pharma and Life Science Channel

03:16 EDT 20th May 2013 | BioPortfolio

PubMed Articles [ 4785 Associated PubMed Articles listed on BioPortfolio]

Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3.

Antisense oligonucleotides (oligos) have been employed against prostate cancer models in both in vivo and in vitro systems. While most target growth factors or their receptors, other oligos are direct...

Secondary mucosa-associated lymphoid tissue (MALT) lymphoma of the colon.

Mucosa-associated lymphoid tissue (MALT)-type lymphomas most commonly occur in the stomach and have been associated with Helicobacter pylori infection. However, MALT-type lymphoma of the colon is a ra...

The prostate cancer-up-regulated myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor.

Prostate cancer (PCa) is one of the most commonly diagnosed malignancies in men and the second leading cause of male cancer mortality. MAZ (Myc-associated zinc-finger protein) is a transcription facto...

A conjugated polymer-peptide hybrid system for prostate-specific antigen (PSA) detection.

We developed fast and readily applicable microarray chips to detect PSA by designing a novel conjugated polymer (energy donor) and combining it with on-chip peptide synthesis. The selective cleavage o...

Single operator choledochoscopy and its role in daily endoscopy routine.

Different diagnostic procedures exist for the detection of bile duct lesions in clinical practice. However, neither retrograde contrast imaging of the bile duct endoscopic retrograde cholangiopancreat...

Actions of oestradiol and progesterone on the prostate in female gerbils: reversal of the histological effects of castration.

Ultra-rapid colorimetric assay for protease detection using magnetic nanoparticle-based biosensors.

Sensitive protease detection methods often require time-consuming techniques and expensive instrumentation. To overcome this limitation, a novel, simple, sensitive and selective colorimetric detection...

An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.

Introduction: Phosphodiesterase type 5 inhibitors (PDE5-i) are used for the oral treatment of erectile dysfunction (ED). Since the launch of sildenafil more than 15 years ago, new molecules have becom...

Urinary and glomerular podocytes in patients with chronic kidney diseases.

BACKGROUNDS: Podocytes are highly differentiated epithelial cells involved in glomerular filtration. This study determines the clinical and histological significance of podocyte detachment and excreti...

Imaging-guided biopsy detects prostate cancer.

News Articles [ 3448 Associated News Articles listed on BioPortfolio]

Major breakthrough in IVF treatment

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a recent study in Reproductive BioMedicine Online on 5-day...

Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial

Columbus, OH (PRWEB) May 19, 2013 The Da Vinci robot lawyers at Wright & Schulte LLC continue to follow developments in the nation’s first trial involving a Da Vinci surgical robot lawsuit...

Woodlands Urologists Offer Comprehensive Men's Health Seminar May 22

Texas Regional Urology doctors will offer a complimentary program discussing current treatment of low testosterone, erectile dysfunction, and prostate health. The Woodlands, Texas (PRWEB) May 19, 2013...

Dr. Allen’s Device Reverses Prostate Enlargement without Side Effects in Contrast to BPH Laser Surgeries and TURP, Highlights Fine Treatment

BPH treatment with Dr. Allen’s Device terminates prostate enlargement at the capillary level without any side effects. While a new study suggests that laser therapy for BPH is equally safe and effec...

Among Patients Carrying BRCA Mutations, PARP Inhibitor Shows Activity In Pancreatic, Prostate Cancers

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be...

Many Texas women who find abnormality on routine mammogram end up in surgical breast biopsy

Many women in Texas who are found to have an abnormality on routine mammogram or discover a lump in one of their breasts end up having an old-fashioned surgical biopsy to find out whether the breast a...

Fuel the Fight Against Prostate Cancer

HMHP Foundation will host a mega car show and family fun event on Sunday, June 9. The event will raise funds for prostate cancer awareness. Boardman, Ohio (PRWEB) May 17, 2013 The HMHP Foundation is...

Clinical data on Cook Medical products to be presented at Digestive Disease Week®

At this week’s Digestive Disease Week (DDW), the world’s largest gathering of physicians and researchers in the gastroenterology field, six abstracts and other clinical data will be presented on C...

Data on Cook Medical Products Presented at Digestive Disease Week®

At this week’s Digestive Disease Week (DDW), the world’s largest gathering of physicians and researchers in the gastroenterology field, six abstracts and other clinical data w...

Tokai Pharmaceuticals in Series E financing deal for $35.5 million

Tokai announced that the pharmaceutical company raised $35.5 million in a Series E financing based on encouraging clinical progress and investor support for galeterone, Tokai’s lead prostate cancer...

Events [ 1 Associated Events listed on BioPortfolio]

Webinar - Oncology Clinical Trials in Eastern Europe

Main focus on Breast cancer, Prostate cancer, Ovarian cancer, Lung cancer, Colorectal cancer

Companies [ 35 Associated Companies listed on BioPortfolio]

Tokai Pharmaceuticals

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, TOK-001, is the first i...

Dendreon Corporation

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of no...

Mitomics

Mitomics is the world leader in the research and development of mitochondrial DNA (mtDNA)-based biomarkers – a new and innovative approach to the detection of cancer and othe...

Sperling Laser Associates

Dan Sperling, MD, D.A.B.R., is the Medical Director at the New Jersey Institute of Radiology, in Carlstadt, N.J. Certified by the American Board of Radiology and licensed in New Y...

MedLumics

Founded in 2009, MedLumics is a medical imaging diagnostics company specializing in advanced optical coherence tomography (OCT) technology. Its proprietary platform technology int...

NxThera

NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The Company’s Rezūm System delivers vapor directly to the prostate to re...

Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, galeterone (TOK-001), i...

Coalition to Cure Prostate Cancer

The Coalition to Cure Prostate Cancer is a philanthropic organization that funds and accelerates advanced prostate cancer research in Canada. Beginning in 2011, the Coalition has...

Epic Sciences, Inc.

Epic Sciences, Inc. (www.epicsciences.com) is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy mat...

Aurora Imaging Technology Inc.

Aurora Imaging Technology Inc. is a private company based in North Andover, Mass. committed to the fight against breast cancer. Aurora strives to manufacture the highest quality a...

Clinical Trials [ 1799 Associated Clinical Trials listed on BioPortfolio]

Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

RATIONALE: Dutasteride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well dutasteride works in tr...

A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy

This is a phase 3, randomized, double-blind, placebo-controlled study to evaluate new or worsening lens opacifications in subjects with non-metastatic prostate cancer receiving denosumab f...

A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumbab Therapy in Patients With Advanced Metastatic Melanoma

This is an open-label, dose-escalation, non-randomized, phase I study in patients with histologically confirmed Stage III or IV melanoma and at least three metastatic cutaneous or subcutan...

Neoadjuvant Axitinib in Prostate Cancer

The goal of this clinical research study is learn if adding axitinib to hormonal therapy can help to control prostate cancer when given before surgery. The safety of this drug will also be...

Testing the Helpfulness of 2 Decision Aids for Prostate Cancer

The purpose of this study is to test different methods for communicating information about prostate cancer treatment to men. The investigators are studying how best to present information...

A Multiple Dose Study of MK-5172 in Hepatitis C-Infected Participants (MK-5172-010 AM1)

This study will compare hepatic pharmacokinetics (PK) derived from liver tissue to plasma PK after administration of MK-5172 to participants with chronic hepatitis C virus (HCV) infection....

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

The purpose of this clinical trial is to find out the effect of epirubicin with estramustine phosphate and celecoxib on PSA and objective response in patients with hormone resistant prosta...

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer

RATIONALE: The use of nutritional supplements, such as selenium, may stop prostate cancer from growing. Internal radiation, such as brachytherapy, uses radioactive material placed directly...

Fulvestrant in Treating Patients With Recurrent Prostate Cancer

RATIONALE: Estrogen may cause the growth of prostate cancer cells. Hormone therapy using fulvestrant may fight prostate cancer by blocking the use of estrogen by the tumor cells. PURPOSE:...

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Risedronate is an orally administered pyridinyl bisphosphonate that is 36 times more potent than pamidronate and 72 times more potent than clodronate. Four randomized, double-blind trials...

Medical and Biotech [MESH] Definitions

Ultrasound, High-intensity Focused, Transrectal

Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer (PROSTATIC NEOPLASMS) and benign prostatic hypertrophy (PROSTATIC HYPERPLASIA).

Carcinoma, Ductal

Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.

Biopsy, Fine-needle

Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.

Colitis, Microscopic

A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.

Colitis, Collagenous

A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show larger-than-normal band of subepithelial COLLAGEN.

Search BioPortfolio:
Advertisement
review and buy Prostate biopsy market research data and corporate reports here

Channels Quicklinks

Advertisement